Janux Therapeutics, Inc.JANXNASDAQ
LOADING
|||
Switch Symbol:
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-44.17M
↓ 54% below average
Average (5y)
$-28.77M
Historical baseline
Range
High:$-3.83M
Low:$-52.42M
CAGR
+63.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-44.17M | +15.7% |
| 2023 | $-52.42M | -6.2% |
| 2022 | $-49.37M | -167.5% |
| 2021 | $-18.46M | -322.5% |
| 2020 | $-4.37M | -14.1% |
| 2019 | $-3.83M | - |